We observed that KDM3B is significantly expressed in RMS cell lines, having the second highest levels of KDM3B expression overall compared to other cancer lines, indicating that it is a potential target for therapy (Supplementary Fig. 3D). This evidence concerns the gene KDM3B and cancer.